Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer

Detalles Bibliográficos
Autores principales:	S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama
Formato:	Artículo
Lenguaje:	English
Publicado:	Elsevier 2020-07-01
Colección:	European Urology Open Science
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2666168320336442

Ejemplares similares

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Hirotake Kodama, et al.
Publicado: (2021-02-01)

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
por: Shingo Hatakeyama, et al.
Publicado: (2013-01-01)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Itsuto Hamano, et al.
Publicado: (2020-07-01)

Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
por: Takuma Narita, et al.
Publicado: (2017-04-01)

Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
por: H. Yamamoto, et al.
Publicado: (2020-07-01)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Ayumu Kusaka, et al.
Publicado: (2014-09-01)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
por: Shogo Hosogoe, et al.
Publicado: (2015-01-01)

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
por: T. Yoneyama, et al.
Publicado: (2020-07-01)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 5 years after ileal neobladder construction
por: T. Narita, et al.
Publicado: (2020-07-01)

Preoperative frailty promotes sarcopenia after radical cystectomy in patients with muscle-invasive bladder cancer
por: T. Narita, et al.
Publicado: (2020-07-01)

Impact of neoadjuvant chemotherapy on Ki67 proliferation index and PDL1 expression in muscle-invasive bladder cancer
por: H. Horiguchi, et al.
Publicado: (2020-07-01)

Advanced glycation end products (AGEs) had significant effect on sleep disorder than nocturia in community-dwelling adults: A 5-year longitudinal study
por: H. Kodama, et al.
Publicado: (2020-07-01)

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer
por: Soma Osamu, et al.
Publicado: (2017-01-01)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
por: Shingo Hatakeyama, et al.
Publicado: (2016-01-01)

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
por: Shingo Hatakeyama, et al.
Publicado: (2016-01-01)

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
por: Yuta Kojima, et al.
Publicado: (2015-01-01)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Naoki Fujita, et al.
Publicado: (2023-04-01)

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study
por: Naoki Fujita, et al.
Publicado: (2022-12-01)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Naoki Fujita, et al.
Publicado: (2022-08-01)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Naoki Fujita, et al.
Publicado: (2023-10-01)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.
por: Naoki Fujita, et al.
Publicado: (2023-01-01)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Takuma Narita, et al.
Publicado: (2017-08-01)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Hiromichi Iwamura, et al.
Publicado: (2022-06-01)

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study
por: Naoki Fujita, et al.
Publicado: (2024-03-01)

Renal metastasis of ovarian granulosa cell tumor
por: Kyo Togashi, et al.
Publicado: (2022-05-01)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
por: Tendo Sato, et al.
Publicado: (2016-01-01)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Yuka Kubota, et al.
Publicado: (2019-07-01)

Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
por: Abrha G Gebrehiwot, et al.
Publicado: (2018-01-01)

A Case of Primary Renal Carcinoid Tumor
por: Toshikazu Tanaka, et al.
Publicado: (2015-01-01)

Outcomes of ABO-blood type incompatible kidney transplantation (ABOi-KT): A single-center study with a contemporary immunosuppression strategy in Japan
por: I. Hamano, et al.
Publicado: (2020-07-01)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.
por: Yoshimi Tanaka, et al.
Publicado: (2017-01-01)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Vincenza Conteduca, et al.
Publicado: (2021-01-01)

Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer
por: Janet E. Brown, et al.
Publicado: (2010-09-01)

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
por: Koichi Uemura, et al.
Publicado: (2018-05-01)

Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
por: Eva Chrenková, et al.
Publicado: (2024-09-01)

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
por: Tomoko Hamaya, et al.
Publicado: (2023-09-01)

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer
por: Takuya Koie, et al.
Publicado: (2020-01-01)

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study
por: Y.K. Kubota, et al.
Publicado: (2020-07-01)

Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
por: Zixi Wu, et al.
Publicado: (2025-12-01)

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
por: Greasley R, et al.
Publicado: (2015-06-01)